Xinyu Wu
Role not yet determined Is this you? Add your title
Also affiliated: Jiangsu University (2019–2020); Central South University (2017–2019); Baylor University (2026); Sun Yat-sen University (2018); Xuzhou Medical College (2021–2024); Yantai University (2023); Xiamen University (2012–2025); Dalian Medical University (2023); Heilongjiang University of Chinese Medicine (2019); Jilin University (2019); Chinese Academy of Sciences (2020–2025); North China University of Water Resources and Electric Power (2025–2026); Huazhong Agricultural University (2015); Qinghai Normal University (2019–2020); Wenzhou Medical University (2024–2025); First Affiliated Hospital of Wenzhou Medical University (2024–2025); Guangzhou Institutes of Biomedicine and Health (2020–2025); Zhengzhou University (2014–2017); Jiangxi Science and Technology Normal University (2022); NYU Langone Health (2014); Changchun Institute of Optics, Fine Mechanics and Physics (2023); Zhejiang Cancer Hospital (2021); Affiliated Hospital of Jiangsu University (2020); Shanghai Institute of Materia Medica (2023); Felix Platter-Hospital (2001); Xinjiang Academy of Agricultural Sciences (2022–2025); Henan Provincial People's Hospital (2014–2017); Drug Discovery Laboratory (Norway) (2018); National Science Library (2025); First Affiliated Hospital of Zhengzhou University (2007); Third Xiangya Hospital (2017–2019); Zhejiang University-University of Edinburgh Institute (2021); Zhejiang Taizhou Hospital (2024); Tongji Hospital (2024–2025); University of Chinese Academy of Sciences (2020–2023); Hangzhou Cancer Hospital (2021); Jiangsu Provincial Key Laboratory of Marine Bioresources and Environment (2022); Huazhong University of Science and Technology (2024–2025); New York University (2011–2016); Shandong Agricultural University (2024); Zhejiang University (2021–2022); China Medical University (2019–2022)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Xinyu Wu's research investigates mechanisms of disease and therapeutic interventions, with a focus on immune responses and molecular signaling pathways. Wu has published work on the role of exosomes derived from granulocytic myeloid-derived suppressor cells in attenuating collagen-induced arthritis by modulating T cell responses and enhancing IL-10+ B cells. Other studies explore the potential of engineered materials for medical applications, such as a ROS-scavenging hydrogel designed to promote scar-free wound healing in infected skin. Wu's work also encompasses computational approaches for cancer classification and the genetic regulation of cellular processes, including pluripotency and prostate gland development. Metrics indicate a substantial publication record, with an h-index of 18 and over 900 citations across 65 publications.
Metrics
- h-index: 18
- Publications: 65
- Citations: 946
Selected Publications
-
A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks (2026)
Collaboration Network
Top Collaborators
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
- A survey on computational pathology foundation models: datasets, adaptation strategies, and evaluation tasks
Similar Researchers
Based on overlapping research topics